跳至主要内容
临床试验/ACTRN12613001106729
ACTRN12613001106729已完成不适用

The effects of zopiclone on obstructive sleep apnoea severity and symptoms of daytime sleepiness and measures of alertness

Woolcock Institute of Medical Research0 个研究点目标入组 30 人开始时间: 2013年10月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Men and women with obstructive sleep apnoea (OSA)

排除标准

  • -People without OSA or who are currently on continuous positive airway pressure therapy for OSA
  • -People with high arousal thresholds (average nadir epiglottic pressure just prior to arousal <-25cmH2O) as determined by overnight polysomnogram (sleep study) during a screening visit.
  • -Known allergy or previous adverse reaction zopiclone
  • -Pregnant or nursing mothers

研究者

相似试验